论文信息 - COMBINATION IBRUTINIB (IBR) AND VENETOCLAX (VEN) FOR THE TREATMENT OF MANTLE CELL LYMPHOMA (MCL): PRIMARY ENDPOINT ASSESSMENT OF THE PHASE 2 AIM STUDY - 字舞流文

COMBINATION IBRUTINIB (IBR) AND VENETOCLAX (VEN) FOR THE TREATMENT OF MANTLE CELL LYMPHOMA (MCL): PRIMARY ENDPOINT ASSESSMENT OF THE PHASE 2 AIM STUDY

S. Dawson | M. Dawson | C. Pott | A. Roberts | C. Tam | R. Hicks | M. Dreyling | M. Bressel | J. Seymour | J. di Iulio | K. Burbury | D. Westerman | R. Agarwal | G. Turner | M. Anderson